Evidence map›Paper›PMID 28302163›Full record

ArticleJournal of neuroinflammation2017

Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activation.

Katherine Conant, Stefano Daniele, P Lorenzo Bozzelli, Tsion Abdi, Amanda Edwards, Arek Szklarczyk, India Olchefske, David Ottenheimer, Kathleen Maguire-Zeiss

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Protocadherins at the Crossroad of Signaling Pathways.Frontiers in molecular neuroscience · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Independent and Combined Effects of Chronic HIV-Infection and Tobacco Smoking on Brain Microstructure.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2018
    Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Katherine ConantDepartment of Neuroscience, Georgetown University School of Medicine, Washington, D.C., USA. kec84@georgetown.edu.
Stefano DanieleDepartment of Neuroscience, Georgetown University School of Medicine, Washington, D.C., USA.
P Lorenzo BozzelliDepartment of Neuroscience, Georgetown University School of Medicine, Washington, D.C., USA.
Tsion AbdiDepartment of Neuroscience, Georgetown University School of Medicine, Washington, D.C., USA.
Amanda EdwardsDepartment of Neuroscience, Georgetown University School of Medicine, Washington, D.C., USA.
Arek SzklarczykJagiellonian Center of Innovation, Krakow, Poland.
India OlchefskeDepartment of Neuroscience, Georgetown University School of Medicine, Washington, D.C., USA.
David OttenheimerDepartment of Neuroscience, Georgetown University School of Medicine, Washington, D.C., USA.
Kathleen Maguire-ZeissDepartment of Neuroscience, Georgetown University School of Medicine, Washington, D.C., USA. Kathleen.maguirezeiss@georgetown.edu.
Georgetown University · USJagiellonian University · PL

Funding

Predoctoral Training in Intergrative NeuroscienceT32NS041231 · NINDS · GEORGETOWN UNIVERSITY · PI Ludise Malkova, Ashley S VanMeter · 2001 to 2026
$6.8M
PAR-1 Signaling and HANDR01NS083410 · NINDS · GEORGETOWN UNIVERSITY · PI CONANT, KATHERINE E, MAGUIRE-ZEISS, KATHLEEN ANNE · 2013 to 2017
$1.9M
MMPs, Integrins and Microglial activation in HANDR21MH096822 · NIMH · GEORGETOWN UNIVERSITY · PI CONANT, KATHERINE E, MAGUIRE-ZEISS, KATHLEEN ANNE · 2012 to 2013
$419k
NIMH NIH HHS R21 MH096822NINDS NIH HHS R01 NS083410NINDS NIH HHS T32 NS041231
6 · The paper itself

Abstract

backgroundMatrix metalloproteinases (MMPs) are a family of enzymes that are typically released from intracellular stores to act on specific extracellular substrates. MMP expression and activity can be increased in a neuronal activity-dependent manner, and further increased in response to tissue injury. MMP substrates include cell adhesion molecules (CAMs) that are abundantly expressed in the brain and well positioned for membrane proximal cleavage. Importantly, CAM integrity is important to synaptic structure and axon-myelin interactions, and shed ectodomains may themselves influence cellular function.

methodsIn the present study, we have examined proteolysis of N-cadherin (N-cdh) by MMP-7, a family member that has been implicated in disorders including HIV dementia, multiple sclerosis, and major depression. With in vitro digest assays, we tested N-cdh cleavage by increasing concentrations of recombinant enzyme. We also tested MMP-7 for its potential to stimulate N-cdh shedding from cultured neural cells. Since select CAM ectodomains may interact with cell surface receptors that are expressed on microglial cells, we subsequently tested the N-cdh ectodomain for its ability to stimulate activation of this cell type as determined by nuclear translocation of NF-κB, Iba-1 expression, and TNF-α release.

resultsWe observed that soluble N-cdh increased Iba-1 levels in microglial lysates, and also increased microglial release of the cytokine TNF-α. Effects were associated with increased NF-κB immunoreactivity in microglial nuclei and diminished by an inhibitor of the toll-like receptor adaptor protein, MyD88.

conclusionsTogether, these in vitro results suggest that soluble N-cdh may represent a novel effector of microglial activation, and that disorders with increased MMP levels may stimulate a cycle in which the products of excess proteolysis further exacerbate microglial-mediated tissue injury. Additional in vivo studies are warranted to address this issue.

Indexed as

ADAM10 ProteinAnimalsAnimals, NewbornCadherinsCalcium-Binding ProteinsCells, CulturedDose-Response Relationship, DrugEnzyme-Linked Immunosorbent AssayMatrix MetalloproteinasesMiceMice, Inbred C57BLMicrofilament ProteinsMicrogliaMyeloid Differentiation Factor 88NF-kappa BOligopeptidesADAM10 ProteinAif1 protein, mousearginyl-glycyl-aspartyl-serineCadherinsCalcium-Binding ProteinsCdh2 protein, mouseMatrix MetalloproteinasesMicrofilament ProteinsMyeloid Differentiation Factor 88NF-kappa BOligopeptidesPlatelet Aggregation InhibitorsMatrix metalloproteinaseMicrogliaMMPMyD88TLRTNFToll-like receptorTumor necrosis factor

Identifiers

PMID28302163
PMCPMC5356362
OpenAlexW2595090075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.